213 related articles for article (PubMed ID: 35140506)
1. ATG16L1 is a Potential Prognostic Biomarker and Immune Signature for Osteosarcoma: A Study Based on Bulk RNA and Single-Cell RNA-Sequencing.
Qin Z; Luo K; Liu Y; Liao S; He J; He M; Xie T; Jiang X; Li B; Liu H; Huang Q; Tang H; Feng W; Zhan X
Int J Gen Med; 2022; 15():1033-1045. PubMed ID: 35140506
[TBL] [Abstract][Full Text] [Related]
2. Analysis of scRNA-seq and bulk RNA-seq demonstrates the effects of EVI2B or CD361 on CD8
Xie T; Feng W; He M; Zhan X; Liao S; He J; Qin Z; Li F; Xu J; Liu Y; Wei Q
Exp Biol Med (Maywood); 2023 Jan; 248(2):130-145. PubMed ID: 36511103
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Prognosis and Immunotherapy Response with a Novel Natural Killer Cell Marker Genes Signature in Osteosarcoma.
Li Q; Huang X; Zhao Y
Cancer Biother Radiopharm; 2023 Oct; ():. PubMed ID: 37889617
[No Abstract] [Full Text] [Related]
4. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma.
Hong X; Fu R
PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294
[TBL] [Abstract][Full Text] [Related]
5. Single-cell RNA datasets and bulk RNA datasets analysis demonstrated
Tu J; Wang D; Zheng X; Liu B
Front Immunol; 2023; 14():911368. PubMed ID: 36814925
[TBL] [Abstract][Full Text] [Related]
6. Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma.
Chen W; Liao Y; Sun P; Tu J; Zou Y; Fang J; Chen Z; Li H; Chen J; Peng Y; Wen L; Xie X
J Transl Med; 2024 Jan; 22(1):66. PubMed ID: 38229155
[TBL] [Abstract][Full Text] [Related]
7. Identification and analysis of a CD8+ T cell-related prognostic signature for colorectal cancer based on bulk RNA sequencing and scRNA sequencing data: A STROBE-compliant retrospective study.
Pan Z; Li Q; Feng Y; Gao C; Pan F
Medicine (Baltimore); 2022 Sep; 101(39):e30758. PubMed ID: 36181098
[TBL] [Abstract][Full Text] [Related]
8. Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma.
Yang J; Zhang J; Na S; Wang Z; Li H; Su Y; Ji L; Tang X; Yang J; Xu L
Front Immunol; 2022; 13():994034. PubMed ID: 36225939
[TBL] [Abstract][Full Text] [Related]
9. Analysis on heterogeneity of hepatocellular carcinoma immune cells and a molecular risk model by integration of scRNA-seq and bulk RNA-seq.
Liu X; Li J; Wang Q; Bai L; Xing J; Hu X; Li S; Li Q
Front Immunol; 2022; 13():1012303. PubMed ID: 36311759
[TBL] [Abstract][Full Text] [Related]
10. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
Front Oncol; 2021; 11():640150. PubMed ID: 33869028
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Immune-Stromal Score-Based Gene Signature and Molecular Subtypes in Osteosarcoma: Implications for Prognosis and Tumor Immune Microenvironment.
Zheng D; Yang K; Chen X; Li Y; Chen Y
Front Genet; 2021; 12():699385. PubMed ID: 34630511
[No Abstract] [Full Text] [Related]
12. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
[TBL] [Abstract][Full Text] [Related]
13. Identification of a seven-gene prognostic signature using the gene expression profile of osteosarcoma.
Liu Z; Zhong Y; Meng S; Liao Q; Chen W
Ann Transl Med; 2022 Jan; 10(2):53. PubMed ID: 35282067
[TBL] [Abstract][Full Text] [Related]
14. Osteosarcoma subtypes based on platelet-related genes and tumor microenvironment characteristics.
Shu Y; Peng J; Feng Z; Hu K; Li T; Zhu P; Cheng T; Hao L
Front Oncol; 2022; 12():941724. PubMed ID: 36212395
[TBL] [Abstract][Full Text] [Related]
15. Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma.
Xiao B; Liu L; Li A; Xiang C; Wang P; Li H; Xiao T
Front Oncol; 2020; 10():607622. PubMed ID: 33384961
[TBL] [Abstract][Full Text] [Related]
16. Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model.
Liang L; Yu J; Li J; Li N; Liu J; Xiu L; Zeng J; Wang T; Wu L
Front Oncol; 2021; 11():711020. PubMed ID: 34621670
[TBL] [Abstract][Full Text] [Related]
17. Single-cell RNA-Seq and bulk RNA-Seq reveal reliable diagnostic and prognostic biomarkers for CRC.
Zhang X; Yang L; Deng Y; Huang Z; Huang H; Wu Y; He B; Hu F
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9805-9821. PubMed ID: 37247080
[TBL] [Abstract][Full Text] [Related]
18. Single-Cell RNA Sequencing Revealed a 3-Gene Panel Predicted the Diagnosis and Prognosis of Thyroid Papillary Carcinoma and Associated With Tumor Immune Microenvironment.
Chen Z; Wang Y; Li D; Le Y; Han Y; Jia L; Yan C; Tian Z; Song W; Li F; Zhao K; He X
Front Oncol; 2022; 12():862313. PubMed ID: 35359404
[TBL] [Abstract][Full Text] [Related]
19. Interaction gene set between osteoclasts and regulatory CD4
Li F; Tang H; Luo X; Li X; Luo K; Liu S; Liang J; Liao S; Zhong C; Zhan X; Wei Q; Feng W; Liu Y
Cancer Sci; 2023 Jul; 114(7):3014-3026. PubMed ID: 37150900
[TBL] [Abstract][Full Text] [Related]
20. Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune Infiltration.
Fu Y; He G; Liu Z; Wang J; Zhang Z; Bao Q; Wen J; Jin Z; Zhang W
J Inflamm Res; 2021; 14():6719-6734. PubMed ID: 34916821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
